Rutherford, NJ, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and ...
CCS’s latest evidence-based research reinforces the most innovative and intelligent approaches to improving adherence and outcomes, while reducing the total costs of diabetes care CHICAGO--(BUSINESS ...
Two posters presented by members of the division received Presidential Poster Awards and were highlighted in the Presidential Poster Session on April 30. “Increasing access to continuous glucose ...
Biomea Fusion, Inc. (“Biomea” or “Biomea Fusion” or “the Company”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today announced that three icovamenib abstracts have been selected for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results